CHM chimeric therapeutics limited

Ann: CHM CDH17 ADVANCES TO DOSE LEVEL 2, page-32

  1. 4,656 Posts.
    lightbulb Created with Sketch. 2152
    A big investor won't invest in a company that is barely staying solvent.

    That's where CHM was, but luckily, that is behind us.

    Overlooking that $2 million shortfall in the SH raise and the $3 plus million shortfall in the options really does make your point mute. Who was it that said "this is the CR we had to have!" or something like that. That it was oversubscribed really builds confidence in the company. That it was wound back, when the purse strings have always been a problem, shows they did their best re dilution. You probably won't agree with that. And that's ok. Its done, and now the pipeline is free to get the party started.



    Financial risk greatly reduced.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.